> top > docs > PMC:7600245 > spans > 71068-71312 > annotations

PMC:7600245 / 71068-71312 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T334 213-221 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T728 57-63 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T729 67-68 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T730 86-91 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T731 240-242 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T77845 17-30 Chemical denotes chlorhexidine http://purl.obolibrary.org/obo/CHEBI_3614
T84072 86-91 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T3791 160-163 Chemical denotes oro http://purl.obolibrary.org/obo/CHEBI_29287

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T554 0-244 Sentence denotes Currently, 0.12% chlorhexidine oral/nasal rinse is being tested in a randomized, open-label, single-institution study so as to evaluate its potential to reduce oro- and naso-pharyngeal viral load in patients with COVID-19 (NCT04344236; n = 48).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2198 199-207 Species denotes patients Tax:9606
2200 17-30 Chemical denotes chlorhexidine MESH:D002710
2203 213-221 Disease denotes COVID-19 MESH:C000657245